Immunocompetent mouse allograft models for development of therapies to target breast cancer metastasis

Effective drug development to combat metastatic disease in breast cancer would be aided by the availability of well-characterized preclinical animal models that (a) metastasize with high efficiency, (b) metastasize in a reasonable time-frame, (c) have an intact immune system, and (d) capture some of...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Oncotarget
Main Authors: Yang, Yuan, Yang, Howard H., Hu, Ying, Watson, Peter H., Liu, Huaitian, Geiger, Thomas R., Anver, Miriam R., Haines, Diana C., Martin, Philip, Green, Jeffrey E., Lee, Maxwell P., Hunter, Kent W., Wakefield, Lalage M.
Formato: Artigo
Idioma:Inglês
Publicado: Impact Journals LLC 2017
Assuntos:
Priority Research Paper
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5458155/
https://ncbi.nlm.nih.gov/pubmed/28430642
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.15695
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares